Predicting Patients at Risk of 30-Day Unplanned Hospital Readmission.

30-days risk of readmission score Acute admissions LACE readmission risk hospitalisation patient at risk of readmission risk of readmission

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
08 Aug 2019
Historique:
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 11 9 2019
Statut: ppublish

Résumé

We developed a machine learning model to predict 30-day readmissions using the model types; XGBoost, Random Forests and Adaboost with decision stumps as a base learner with different feature combinations and preprocessing procedures. The proposed model achieved the F1-score (0.386 ± 0.006), sensitivity (0.598 ± 0.013), positive predictive value (PPV) (0.285 ± 0.004) and negative predictive value (NPV) (0.932 ± 0.002). When compared with LACE and PARR (NZ) models, the proposed model achieved better F1-score by 12.5% compared to LACE and 22.9% compared to PARR (NZ). The mean sensitivity of the proposed model was 6.0% higher than LACE and 42.4% higher than PARR (NZ). The mean PPV was 15.9% and 13.5% higher than LACE and PARR (NZ) respectively.

Identifiants

pubmed: 31397296
pii: SHTI190767
doi: 10.3233/SHTI190767
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20-24

Auteurs

Mirza Baig (M)

Data Science Team, Orion Health.

Ning Hua (N)

Data Science Team, Orion Health.

Edmond Zhang (E)

Data Science Team, Orion Health.

Reece Robinson (R)

Data Science Team, Orion Health.

Delwyn Armstrong (D)

North Shore Hospital, Waitemata District Health Board.

Robyn Whittaker (R)

North Shore Hospital, Waitemata District Health Board.

Tom Robinson (T)

North Shore Hospital, Waitemata District Health Board.

Farhaan Mirza (F)

Auckland University of Technology.

Ehsan Ullah (E)

Clinical Quality & Safety Service, Auckland City, Auckland District Health Board.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH